Key result
Echocardiography enables critical pre-symptomatic risk stratification and detects early cardiac dysfunction in patients with diabetes.
Why the study?
Pre-symptomatic assessment is critical for managing diabetic patients given rising morbidity and mortality with target organ damage, and echocardiographic techniques can detect early alteration in cardiac function.
Answers are grounded in this paper and cite their sources.
Echocardiography is highlighted as a critical noninvasive tool for the pre-symptomatic assessment, risk stratification, and detection of early cardiac dysfunction in diabetic patients.
Diabetes mellitus is a major factor contributing to the development of cardiovascular disease. As morbidity and mortality rates rise dramatically, when target organ damage develops pre-symptomatic assessment is critical for the management of diabetic patients. Echocardiography is a noninvasive and reproducible method that may aid in risk stratification and in evaluation of treatment effects. The aim of this review is to analyze the echocardiographic techniques which can detect early alteration in cardiac function in patients with diabetes.
No takes yet. Share an insight, caveat, or question.
Katogiannis et al. (2020) conducted a review in Diabetes mellitus. Echocardiography was evaluated. Echocardiography serves as a critical noninvasive tool for pre-symptomatic assessment, risk stratification, and detection of early cardiac function alterations in patients with diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: